Cargando…
Osteopontin splice variants are differential predictors of breast cancer treatment responses
BACKGROUND: Osteopontin is a marker for breast cancer progression, which in previous studies has also been associated with resistance to certain anti-cancer therapies. It is not known which splice variants may mediate treatment resistance. METHODS: Here we analyze the association of osteopontin vari...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940753/ https://www.ncbi.nlm.nih.gov/pubmed/27400751 http://dx.doi.org/10.1186/s12885-016-2484-x |